IMNM
IMNM
NASDAQ · Biotechnology

Immunome Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$19.21
+0.47 (+2.51%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 20 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +584.5% upside
Low Target $82.08
Average Target $131.49
High Target $141.61
Current Price $19.21
Current
$19.21
Target
$131.49
$82.08 $131.49 avg $141.61
Scenario Analysis
Bear Case
$82.08
327.3%
Low target
Base Case
$131.49
+584.5%
Avg target
Bull Case
$141.61
+637.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$27.65
-30.5% from high
52-Week Low
$7.96
+141.3% from low
50-Day SMA
$22.49
-14.6% vs SMA
200-Day SMA
$14.32
+34.1% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$131.49
+375.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%